Zimbabwe has rejected a significant US healthcare agreement worth $367m (£272m) spanning five years because of Washington's insistence on sensitive biological samples.
This rejection came to light following a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesperson has since stated that the United States was requesting health data for research and profit while was unwilling to share the benefits from future treatments.
"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued dialogue to reach a deal agreeable to all parties so the country's critical HIV treatment initiative can be sustained.
Wider Context
This development follows a comparable situation in Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the safety of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance openness and responsibility.
Based on reports, 16 nations in Africa have to date agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Rejected Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to provide its biological resources and data for a long time, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery without any assurance that the final treatments would be available to our people should a future health crisis arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting systems already set up through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.
"This framework is designed to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
These objections over the US deal "must not be interpreted as opposition to America," he added.
"We encourage further discussions with our US partners on how future co-operation might be structured in a way that honours the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but suggested that negotiations should continue given that much of the country's Aids initiatives depended on external financing.
"If technical issues exist, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," the group said.
The halted deal highlights the continuing debate between accepting much-needed foreign assistance and protecting a country's data in an increasingly data-driven world.